Latest blog articles
-
The IMCO Committee is trying to amend the Unfair Commercial Practices Directive (2005/29) to include a ban on dark patterns. The proposed amendments are part of the EU’s plans to empower consumers for the green transition and the Parliament is expected to address the proposed amendments on 17 April...
-
Over the weekend of March 25-26, TikTok users started sharing videos of their experiences trying to delete their Instagram accounts on Android devices. Users took issue with not being able to delete their accounts via the Instagram app and having to use a desktop/mobile browser to complete the...
-
Only a short drive from Maastricht, border stones still mark the borders of Neutral Moresnet, a small condominium that was the result of a very peculiar round of border negotiations and for over a hundred years was a tax haven, a gambling paradise and a would-be Esperanto state.
-
Throughout the EU, the rights of asylum seekers come under pressure. Overdue policy changes remain stuck in negotiations because of lacking political will. It is up to the European Commission to step up and protect the fundamental rights of asylum seekers.
-
How do we guarantee access to COVID-19 vaccines and therapies, and secure health-related human rights for all? We’ve heard a string of promises in the race for new vaccines and therapies.
-
It’s been almost a month since the COVID-19 pandemic has drastically changed the way we live and work. Now that we are more used to, in a manner of speaking, the extraordinary measures to curtail the rampant spread of the virus, it’s time to seriously consider, and openly discuss, this crisis’...
-
As you may or may not know, Cyprus is a divided island. While the south of the island is governed by the internationally recognized Republic of Cyprus, the north is governed by the "Turkish Republic of Northern Cyprus", an internationally unrecognized state.
-
Globally the majority of health-related R&D is invested in medicines with substantial guaranteed returns, yet what is missing is extensive R&D targeted at diseases overwhelmingly prevalent in developing countries. This threatens long-term availability of medicines and treatment options for these...